Desktop Site
|
24 Apr 24 | 13:47
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,993.09
+254.64
+0.35 %
Corporate Announcement
Security Code
532296
Company
GLENMARK PHARMACEUTICALS LTD.
Exchange Received Time
20/09/2017 08:47:06
Exchange Disseminated Time
20/09/2017 08:47:09
Time Taken
00:00:03
Press Release / Media Release |
9/20/2017 8:47:06 AM
Sub: Glenmark Pharmaceuticals receives ANDA approval for Nitroglycerin Sublingual Tablets USP, 0.3 mg, 0.4 mg, and 0.6 mg
With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.
Request you to kindly take the same on record.
Attachment
<< Back
Recently Viewed